Elixinol Wellness (EXL.AX) Stock Price
Elixinol Wellness Price
Revenue at Elixinol Wellness has contracted by 9.1% per year over the past 23 years to 15.50 M AUD. Earnings per share have grown at 56.7% per year over the last 3 years. For Elixinol Wellness, the net margin of -35.5% is up versus -182.3% a few years ago.
Elixinol Wellness stock price
Elixinol Wellness business model & stock analysis
Frequently asked questions about Elixinol Wellness
5 analysts currently rate the Elixinol Wellness stock: 4 recommend buying, 1 holding and 0 selling.
Converted at the current exchange rate, the Elixinol Wellness share trades at 0.00 EUR (0.01 AUD).
The Elixinol Wellness share (EXL.AX) is listed on 4 stock exchanges, including: ASX (EXL.AX), Frankfurt (E8M.F), München (E8M.MU).
The revenue cannot currently be calculated for Elixinol Wellness.
The profit cannot currently be calculated for Elixinol Wellness.
The P/E ratio cannot be calculated for Elixinol Wellness at the moment.
The P/S cannot be calculated for Elixinol Wellness currently.
The Eulerpool Quality Score for Elixinol Wellness is 2/10.
The ISIN of Elixinol Wellness is AU000000EXL4. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The WKN of Elixinol Wellness is A2JB8D. The WKN (Wertpapierkennnummer) is a six-digit German security identification number.
The ticker of Elixinol Wellness is EXL.AX. The ticker symbol is used to trade Elixinol Wellness shares on the stock exchange.
Elixinol Wellness stock
Elixinol Wellness Peer Group
Elixinol Wellness Ticker
Elixinol Wellness FIGI
All fundamentals and in-depth analysis of Elixinol Wellness
Our stock analysis for Elixinol Wellness stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Elixinol Wellness. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.